Vesalius


Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.
Related to Vesalius: Galileo

Vesalius

 [vĕ-sa´le-us]
Andreas (1514–1564). Flemish anatomist and physician, considered the most eminent anatomist of the 16th century. His De humani corporis fabrica libri septum (Seven Books on the Structure of the Human Body) was published in 1543. He was also a pioneer in ethnic craniology and experimental and comparative psychology.

Ve·sa·li·us

(WesalVesal) (vĕ-sā'lē-ŭs),
Andreas (Andre), Flemish anatomist, 1514-1564. See: Vesalius bone, Vesalius foramen, Vesalius vein.
References in periodicals archive ?
Out of the thirty skulls examined, nine skulls showed the presence of foramen Vesalius (incidence being 30%).
Measurement accuracy of foramen of vesalius for safe percutaneous techniques using computerassisted three-dimensional landmarks.
Ironically, there is more to this unnaturally lively, self-proffering, autoptic ecorche, as can be noticed already in the title page of Vesalius's Fabrica, an engraving otherwise rightly celebrated for its metaphorical and theatricalised statement of the purpose and means of early modern anatomy (Sawday 66-72).
Early in 1538, Vesalius was preparing his Tabula anatomice sex (Six anatomical plates) for publication.
Vesalius identified errors in Galen's texts, particularly the fact that Galenic anatomy was based on animal, not human, dissections.
Vesalius himself offers a recipe for preparing bodies for dissection, and he tells us that Galen was reluctant himself to flay the apes he was about to anatomize.
Significant works of Renaissance anatomy, such as Andreas Vesalius's Dehumani corporisfabrica (1543), mark a period in which the cutaway offered the most advanced medical imaging in existence, rendered directly by skilled draftsmen from observation of pioneering dissections conducted by the work's author.
Wim Robberecht, MD, PhD, lead investigator of the latest study and a researcher at the University of Leuven in Belgium and the Vesalius Research Center, screened for genes in zebrafish that blunt the adverse effect of the ALS mutant gene SOD1.
Gaston Matthyssens, chairman of board and managing partner at Vesalius Biocapital.